H. Res. 419 (119th)Bill Overview

Expressing support for the designation of May 17, 2025, as "DIPG Awareness Day" to raise awareness and encourage research into cures for diffuse intrinsic pontine glioma (DIPG) and pediatric cancers in general.

Simple ResolutionHealth|Health
Cosponsors
Support
Lean Democratic
Introduced
May 15, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Simple ResolutionWhat this resolution actually does

This resolution is a non-binding statement from the House of Representatives that supports designating May 17, 2025, as DIPG Awareness Day and encourages awareness and research into DIPG and pediatric cancers. It does not create new law, change federal programs, or provide funding. It expresses the House's views and urges public and private groups to prioritize research and consider mortality and life-years lost when awarding grants.

This House resolution designates May 17, 2025, as “DIPG Awareness Day,” encourages public awareness of diffuse intrinsic pontine glioma (DIPG) and pediatric cancers, supports expanded research and comprehensive care, and urges public and private funders to weigh mortality and life-years lost when awarding grants.

Passage15/100

Text is symbolic and nonbinding; likely to be adopted in the originating chamber but not to become binding law without separate statutory vehicle.

CredibilityAligned

Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the problem and purpose, uses conventional symbolic mechanisms, and contains minimal implementation, fiscal, or oversight detail appropriate to such a resolution.

Contention18/100

Degree of comfort with calls to increase federal research funding

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Families · Federal agenciesLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • FamiliesIncreased public awareness could raise donations for DIPG research and family support services.
  • Federal agenciesHeightened congressional attention may encourage federal and private funders to reconsider pediatric brain tumor priori…
  • WorkersGreater visibility could accelerate researcher collaboration and interest in DIPG studies and clinical trials.
Likely burdened
  • Potential burdenThe resolution is symbolic and does not appropriate funds, so direct funding changes are unlikely.
  • Potential burdenEmphasizing life-years lost may shift limited research dollars away from other diseases or age groups.
  • Potential burdenIt could create public expectations for new spending absent any budgetary authorization.
03 · Why people split

Why the argument around this bill splits.

Degree of comfort with calls to increase federal research funding
Progressive95%

Generally strongly supportive: the resolution highlights a severe pediatric cancer with very poor survival and explicitly calls for more federal research funding.

Liberals will view it as a useful symbolic step and a platform to push for concrete increases in research dollars and attention to pediatric oncology.

Leans supportive
Centrist90%

Largely supportive as a bipartisan, low-risk resolution raising awareness about a severe childhood cancer.

Centrists will welcome the focus on mortality and life-years lost but want clarity about costs and how recommendations will translate into effective, evidence-based funding decisions.

Leans supportive
Conservative75%

Generally positive about awareness and research encouragement, but cautious about the resolution’s explicit call to increase federal research funding.

Conservatives will favor private philanthropy, state-led efforts, and oppose open-ended federal spending without offsets or clear program details.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood15/100

Text is symbolic and nonbinding; likely to be adopted in the originating chamber but not to become binding law without separate statutory vehicle.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether committee will schedule the resolution for consideration
  • Whether a companion Senate resolution will be introduced
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Degree of comfort with calls to increase federal research funding

Text is symbolic and nonbinding; likely to be adopted in the originating chamber but not to become binding law without separate statutory v…

Unlocked analysis

Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the problem and purpose, uses conventional symbolic mechanisms, and contains minimal implementation…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis